Basic Materials Market Research Report
Report Filter Reset All
Sort By Price
Published Date
Category
Publishers
Report Type
Continents
Regions
Global Edoxaban API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Edoxaban is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. According to our (Global Info Research) latest study, the global Edoxaban ...
$3,480.00 16 February, 2023 | GIR (Global Info Research)
Global Edoxaban API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
$3,480.00 | 16 February, 2023 | GIR (Global Info Research)
Edoxaban is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. According to our (Global Info Research) latest study, the global...
Edoxaban is an oral factor Xa (FXa) inhibitor, also contraindicated in patients with active pathological bleeding. According to our (Global Info Research) la...
$3,480.00 16 February, 2023 | GIR (Global Info Research)
Global Edoxaban Reagent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
$3,480.00 | 16 February, 2023 | GIR (Global Info Research)
Edoxaban is an oral factor Xa (FXa) inhibitor, also contraindicated in patients with active pathological bleeding. According to our (Global Info Re...
Eliglustat is a specific and potent inhibitor of glucosylceramide synthase. According to our (Global Info Research) latest study, the global Eliglustat Reage...
$3,480.00 16 February, 2023 | GIR (Global Info Research)
Global Eliglustat Reagent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
$3,480.00 | 16 February, 2023 | GIR (Global Info Research)
Eliglustat is a specific and potent inhibitor of glucosylceramide synthase. According to our (Global Info Research) latest study, the global Eliglu...
Global Eliglustat API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Eliglustat is a glucosylceramide synthase inhibitor indicated for the long-term treatment of type 1 Gaucher disease in patients who are CYP2D6 extensive meta...
$3,480.00 16 February, 2023 | GIR (Global Info Research)
Global Eliglustat API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
$3,480.00 | 16 February, 2023 | GIR (Global Info Research)
Eliglustat is a glucosylceramide synthase inhibitor indicated for the long-term treatment of type 1 Gaucher disease in patients who are CYP2D6 exte...
Eliglustat tartrate is a specific inhibitor of glucosylceramide synthase. It is under development as an oral substrate reduction therapy for Gaucher disease ...
$3,480.00 16 February, 2023 | GIR (Global Info Research)
Global Eliglustat Tartrate Reagent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
$3,480.00 | 16 February, 2023 | GIR (Global Info Research)
Eliglustat tartrate is a specific inhibitor of glucosylceramide synthase. It is under development as an oral substrate reduction therapy for Gauche...
Eliglustat tartrate is a tartrate that is the hemitartrate salt of eliglustat. According to our (Global Info Research) latest study, the global Eliglustat Ta...
$3,480.00 16 February, 2023 | GIR (Global Info Research)
Global Eliglustat Tartrate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
$3,480.00 | 16 February, 2023 | GIR (Global Info Research)
Eliglustat tartrate is a tartrate that is the hemitartrate salt of eliglustat. According to our (Global Info Research) latest study, the global Eli...
Eluxadoline is a novel, orally-active drug approved for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel...
$3,480.00 16 February, 2023 | GIR (Global Info Research)
Global Eluxadoline Reagent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
$3,480.00 | 16 February, 2023 | GIR (Global Info Research)
Eluxadoline is a novel, orally-active drug approved for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irrit...
Global Eluxadoline API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Eluxadoline is a medication taken by mouth for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel syndrome...
$3,480.00 16 February, 2023 | GIR (Global Info Research)
Global Eluxadoline API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
$3,480.00 | 16 February, 2023 | GIR (Global Info Research)
Eluxadoline is a medication taken by mouth for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowe...
Eslicarbazepine acetate,an antiepileptic drug, is a dual a dual Inhibitor of β-Secretase and voltage-gated sodium channel. According to our (Global Info Rese...
$3,480.00 16 February, 2023 | GIR (Global Info Research)
Global Eslicarbazepine Acetate Reagent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
$3,480.00 | 16 February, 2023 | GIR (Global Info Research)
Eslicarbazepine acetate,an antiepileptic drug, is a dual a dual Inhibitor of β-Secretase and voltage-gated sodium channel. According to our (Global...
Eslicarbazepine acetate is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or as additional therapy for partial-...
$3,480.00 16 February, 2023 | GIR (Global Info Research)
Global Eslicarbazepine Acetate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
$3,480.00 | 16 February, 2023 | GIR (Global Info Research)
Eslicarbazepine acetate is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or as additional therapy fo...
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
